Internal Medicine, Interventional Cardiology · Sun City West, AZ
NPI
1750338927
Since 2006
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
14420 W Meeker Blvd Ste 203
Sun City West, AZ, 85375
Phone (623) 876-3810
Groups this clinician bills Medicare through
Medicare paid, 2024
$447K
6,139 services
Medicare patients, 2024
1,400
Average age 79
Drug cost, 2024
$1.9M
10,271 prescriptions
Company payments, 2025
$742
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mihaela T Rosetti was code 99214 (office e&m - established), 1,589 times for 918 patients. In total Mihaela T Rosetti billed 6,139 services in 79 codes, and Medicare paid $447K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,589 | 918 | $90.06 | $143K |
| 99213 Office E&M - Established | Office | 539 | 430 | $63.75 | $34K |
| 93000 Electrocardiogram | Office | 529 | 510 | $9.83 | $5,199 |
| 93793 Care Management/Coordination | Office | 353 | 31 | $8.29 | $2,926 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 340 | 85 | $5.36 | $1,824 |
| 93306 Echocardiography (TTE/TEE) | Office | 299 | 296 | $139.15 | $42K |
| 93296 External Electrocardiographic Monitoring | Office | 259 | 101 | $15.29 | $3,961 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 224 | 112 | $143.55 | $32K |
| 93294 External Electrocardiographic Monitoring | Office | 219 | 86 | $20.80 | $4,556 |
| 99232 Hospital E&M - Subsequent | Facility | 202 | 102 | $59.82 | $12K |
| 93015 Electrocardiogram | Office | 139 | 134 | $48.17 | $6,695 |
| 99204 Office E&M - New | Office | 135 | 135 | $116.60 | $16K |
| 93306 Echocardiography (TTE/TEE) | Facility | 132 | 128 | $49.86 | $6,582 |
| 93298 External Electrocardiographic Monitoring | Office | 130 | 29 | $65.57 | $8,524 |
| 78452 Myocardial Perfusion Scan | Office | 112 | 112 | $324.86 | $36K |
By year: 2022 $336K for 5,009 services; 2023 $445K for 6,030 services; 2024 $447K for 6,139 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 224 | 39 | $4.20 | $941 |
Medicare prescription drug claims, 2024
In 2024, the drug Mihaela T Rosetti prescribed most often to Medicare patients was Rosuvastatin Calcium, with 899 prescriptions and refills. In total Mihaela T Rosetti wrote 10,271 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 899 | 2,511 | 286 | $11K |
| Eliquis Apixaban | 866 | 2,054 | 234 | $1.2M |
| Amlodipine Besylate Generic | 837 | 2,301 | 253 | $4,243 |
| Metoprolol Succinate Generic | 836 | 2,408 | 259 | $10K |
| Atorvastatin Calcium Generic | 710 | 2,108 | 226 | $7,917 |
| Lisinopril Generic | 638 | 1,793 | 203 | $4,435 |
| Losartan Potassium Generic | 558 | 1,555 | 174 | $6,012 |
| Furosemide Generic | 480 | 1,258 | 163 | $2,583 |
| Carvedilol Generic | 362 | 992 | 109 | $3,368 |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 355 | 994 | 110 | $11K |
| Metoprolol Tartrate Generic | 302 | 833 | 102 | $2,064 |
| Hydralazine Hcl Generic | 246 | 696 | 79 | $3,788 |
| Clopidogrel Clopidogrel Bisulfate | 230 | 677 | 85 | $3,341 |
| Clonidine Hcl Generic | 200 | 501 | 67 | $1,483 |
| Xarelto Rivaroxaban | 162 | 348 | 53 | $188K |
Brand drugs: - claims; generic drugs: 8,843 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mihaela T Rosetti $742 ($742 in general payments such as food, travel and fees) from 8 companies. The largest payer was Boston Scientific Corporation with $400.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.